Services


Bioscience Valuation offers the following services:



Financial evaluation and risk analysis of R&D projects, portfolios, marketed products, technology platforms and companies

  • development of detailed financial models providing project, portfolio, product, platform technology or company value
  • analyzing R&D-related technical risks and increasing the probability of discovery and development success
  • generation of sales forecasts and development of market penetration models (together with Bioscience Market Research)
  • assessing commercial risks and increasing the probability of commercial success (together with Bioscience Market Research)
  • investigation of R&D strategies to minimize risk and to enhance project value
  • strategy development for value-driven life cycle management

    see Approach: Project valuation and value-driven project management

    back to top



Portfolio evaluation and optimization

  • quantitative and qualitative analysis to support project prioritization and selection
  • improvement of resource allocation in order to create the most efficient portfolio
  • calculation and analysis of expected portfolio cash flows
  • gap analysis and design of strategies to increase portfolio value
  • optimization of the R&D and product portfolio with respect to the client’s strategic objectives and risk preference
  • support for the strategic planning process

    see Approach: Portfolio evaluation and optimization

    back to top



Implementation of value-driven project and portfolio management



Company valuation and fund raising

  • determination of company value in order to prepare for a financing round
  • identifying and approaching potential investors
  • organization of road shows and support in preparing the company presentation
  • defending the valuation vis-à-vis potential investors
  • negotiation of deal terms

    see Approach: Company valuation and fund raising

    back to top



Determination of fair and value-maximizing partnering and licensing conditions

  • assessment of the financial value of a licensing candidate, technology platform, or a firm’s contribution to a collaboration
  • fair risk-sharing between licensing partners towards a win-win scenario
  • finding the right balance between upfront payments, milestone payments, equity transfers and royalties
  • evaluating and integrating options in the partnering agreement
  • support during licensing negotiations

    see Approach: Licensing and partnering

    back to top



Evaluation of research and technology investments as real options

  • determination of the option value of strategic research and technology investments
  • identifying and assessing a project’s strategic opportunities
  • evaluation of operating and growth options

    see Approach: Real options

    back to top